Treatment of cone photoreceptors is of relevance because mutations in CRX also cause milder adult-onset cone-rod dystrophies and macular dystrophies, which could potentially benefit from gene therapy treatment described here. The gene discussed is CRX; the disease is Rod-cone dystrophy.